In Hong Kong’s largest biotech IPO of the year, antibody company Akeso raises $333M

Akeso raised HK$2.6 billion Thursday in the second and largest IPO this year on the Hong Kong exchange's biotech chapter, valuing the company at HK$12.3 billion.

Akeso Inc. (HKEX:9926) sold 159.5 million shares at HK$16.18, the top of its proposed range of HK$14.88-HK$16.18.

Both of

Read the full 446 word article

How to gain access

Continue reading with a
two-week free trial.